Figure 7From: Potential carriers of chemotherapeutic drugs: matrix based nanoparticulate polymeric systems The relative tumour uptake of PETRA crosslinked PEGDA formulation (PP1) compared to the contralateral normal muscle (tumour:muscle ratio) over a period of 24 h. Back to article page